BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

567 related articles for article (PubMed ID: 12451136)

  • 1. Nogo-A and myelin-associated glycoprotein mediate neurite growth inhibition by antagonistic regulation of RhoA and Rac1.
    Niederöst B; Oertle T; Fritsche J; McKinney RA; Bandtlow CE
    J Neurosci; 2002 Dec; 22(23):10368-76. PubMed ID: 12451136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regeneration in the central nervous system.
    Bandtlow CE
    Exp Gerontol; 2003; 38(1-2):79-86. PubMed ID: 12543264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P75 interacts with the Nogo receptor as a co-receptor for Nogo, MAG and OMgp.
    Wang KC; Kim JA; Sivasankaran R; Segal R; He Z
    Nature; 2002 Nov; 420(6911):74-8. PubMed ID: 12422217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Versican V2 and the central inhibitory domain of Nogo-A inhibit neurite growth via p75NTR/NgR-independent pathways that converge at RhoA.
    Schweigreiter R; Walmsley AR; Niederöst B; Zimmermann DR; Oertle T; Casademunt E; Frentzel S; Dechant G; Mir A; Bandtlow CE
    Mol Cell Neurosci; 2004 Oct; 27(2):163-74. PubMed ID: 15485772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myelin-associated glycoprotein as a functional ligand for the Nogo-66 receptor.
    Liu BP; Fournier A; GrandPré T; Strittmatter SM
    Science; 2002 Aug; 297(5584):1190-3. PubMed ID: 12089450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth.
    Wang KC; Koprivica V; Kim JA; Sivasankaran R; Guo Y; Neve RL; He Z
    Nature; 2002 Jun; 417(6892):941-4. PubMed ID: 12068310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myelin-associated glycoprotein interacts with the Nogo66 receptor to inhibit neurite outgrowth.
    Domeniconi M; Cao Z; Spencer T; Sivasankaran R; Wang K; Nikulina E; Kimura N; Cai H; Deng K; Gao Y; He Z; Filbin M
    Neuron; 2002 Jul; 35(2):283-90. PubMed ID: 12160746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and function of myelin-associated proteins and their common receptor NgR on oligodendrocyte progenitor cells.
    Huang JY; Wang YX; Gu WL; Fu SL; Li Y; Huang LD; Zhao Z; Hang Q; Zhu HQ; Lu PH
    Brain Res; 2012 Feb; 1437():1-15. PubMed ID: 22227458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Truncated soluble Nogo receptor binds Nogo-66 and blocks inhibition of axon growth by myelin.
    Fournier AE; Gould GC; Liu BP; Strittmatter SM
    J Neurosci; 2002 Oct; 22(20):8876-83. PubMed ID: 12388594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroscience. It takes more than two to Nogo.
    Woolf CJ; Bloechlinger S
    Science; 2002 Aug; 297(5584):1132-4. PubMed ID: 12183616
    [No Abstract]   [Full Text] [Related]  

  • 11. Molecular basis of the interactions of the Nogo-66 receptor and its homolog NgR2 with myelin-associated glycoprotein: development of NgROMNI-Fc, a novel antagonist of CNS myelin inhibition.
    Robak LA; Venkatesh K; Lee H; Raiker SJ; Duan Y; Lee-Osbourne J; Hofer T; Mage RG; Rader C; Giger RJ
    J Neurosci; 2009 May; 29(18):5768-83. PubMed ID: 19420245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small Nogo-66-binding peptide promotes neurite outgrowth through RhoA inhibition after spinal cord injury.
    Deng Q; Cai W; Li S; Zhang Y; Su B
    Brain Res Bull; 2013 Oct; 99():140-4. PubMed ID: 24184005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Nogo-66 receptor NgR1 is required only for the acute growth cone-collapsing but not the chronic growth-inhibitory actions of myelin inhibitors.
    Chivatakarn O; Kaneko S; He Z; Tessier-Lavigne M; Giger RJ
    J Neurosci; 2007 Jul; 27(27):7117-24. PubMed ID: 17611264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TAJ/TROY, an orphan TNF receptor family member, binds Nogo-66 receptor 1 and regulates axonal regeneration.
    Shao Z; Browning JL; Lee X; Scott ML; Shulga-Morskaya S; Allaire N; Thill G; Levesque M; Sah D; McCoy JM; Murray B; Jung V; Pepinsky RB; Mi S
    Neuron; 2005 Feb; 45(3):353-9. PubMed ID: 15694322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myelin-associated glycoprotein modulates apoptosis of motoneurons during early postnatal development via NgR/p75(NTR) receptor-mediated activation of RhoA signaling pathways.
    Palandri A; Salvador VR; Wojnacki J; Vivinetto AL; Schnaar RL; Lopez PH
    Cell Death Dis; 2015 Sep; 6(9):e1876. PubMed ID: 26335717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RhoA inhibits the nerve growth factor-induced Rac1 activation through Rho-associated kinase-dependent pathway.
    Yamaguchi Y; Katoh H; Yasui H; Mori K; Negishi M
    J Biol Chem; 2001 Jun; 276(22):18977-83. PubMed ID: 11279039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localisation and expression of a myelin associated neurite inhibitor, Nogo-A and its receptor Nogo-receptor by mammalian CNS cells.
    Nyatia E; Lang DM
    Res Vet Sci; 2007 Dec; 83(3):287-301. PubMed ID: 17428512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nogo-A inhibits neurite outgrowth and cell spreading with three discrete regions.
    Oertle T; van der Haar ME; Bandtlow CE; Robeva A; Burfeind P; Buss A; Huber AB; Simonen M; Schnell L; Brösamle C; Kaupmann K; Vallon R; Schwab ME
    J Neurosci; 2003 Jul; 23(13):5393-406. PubMed ID: 12843238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nogo-66 receptor prevents raphespinal and rubrospinal axon regeneration and limits functional recovery from spinal cord injury.
    Kim JE; Liu BP; Park JH; Strittmatter SM
    Neuron; 2004 Oct; 44(3):439-51. PubMed ID: 15504325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promotion of axon regeneration by myelin-associated glycoprotein and Nogo through divergent signals downstream of Gi/G.
    Hasegawa Y; Fujitani M; Hata K; Tohyama M; Yamagishi S; Yamashita T
    J Neurosci; 2004 Jul; 24(30):6826-32. PubMed ID: 15282288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.